Schedule 13D ownership disclosure

WEREWOLF THERAPEUTICS INC

Common Stock · CUSIP: 95075A107

Event date: 2025-12-22

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • MPM BioVentures 2014, L.P.Reported CIK 0001609492

    Shares: 1,725,184.00 · Class: 3.6%

  • MPM BioVentures 2014 (B), L.P.Reported CIK 0001609493

    Shares: 115,066.00 · Class: 0.2%

  • MPM Asset Management Investors BV2014 LLCReported CIK 0001609495

    Shares: 59,379.00 · Class: 0.1%

  • UBS Oncology Impact Fund L.P.Reported CIK 0001691428

    Shares: 1,426,938.00 · Class: 2.9%

  • MPM BioVentures 2014 GP LLCReported CIK 0001765091

    Shares: 1,840,250.00 · Class: 3.8%

  • MPM BioVentures 2014 LLCReported CIK 0001765021

    Shares: 1,899,629.00 · Class: 3.9%

  • Oncology Impact Fund (Cayman) Management L.P.Reported CIK 0001721036

    Shares: 1,426,938.00 · Class: 2.9%

  • MPM BioImpact LLCReported CIK 0001687078

    Shares: 1,426,938.00 · Class: 2.9%

  • ANSBERT GADICKEReported CIK 0001134655

    Shares: 3,977,612.00 · Class: 8.2%

  • LUKE EVNINReported CIK 0001134657

    Shares: 2,550,674.00 · Class: 5.3%

  • Todd FoleyReported CIK 0001473930

    Shares: 1,899,629.00 · Class: 3.9%

  • MPM ASSET MANAGEMENT LLCReported CIK 0001263048

    Shares: 273,218.00 · Class: 0.6%

  • MPM ONCOLOGY INNOVATIONS FUND LPReported CIK 0001719960

    Shares: 377,827.00 · Class: 0.8%

  • MPM Oncology Innovations Fund GP LLCReported CIK 0001857903

    Shares: 377,827.00 · Class: 0.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001231919-25-000666
Form type
SCHEDULE 13D/A
Filer
MPM BioVentures 2014, L.P.
CIK
CIK 1609492
Filed
Dec 29, 2025
Reporting period
Dec 22, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub